| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | GameSquare Holdings, Inc.: GameSquare's Stream Hatchet Recaps 2024's Biggest Live Streaming Trends in its Save Point 2024 Report | The Save Point 2024 report looks back at the year's newest live-streaming platforms, the most popular streamers, top games, new alternative content capturing viewer interest, and the new meta for esportsView... ► Artikel lesen | |
| Di | GameSquare brings SpongeBob SquarePants to Fortnite | ||
| Di | GameSquare Holdings, Inc.: GameSquare Announces Latest Fortnite UEFN Campaign with Nickelodeon's SpongeBob SquarePants | Launch Of Four Immersive UEFN Experiences Marks The Arrival Of Nickelodeon's SpongeBob SquarePants To The Fortnite PlatformWatch Trailer here FRISCO, TX / ACCESSWIRE / December 17, 2024 / Zoned, a GameSquare... ► Artikel lesen | |
| 21.11. | GameSquare Holdings, Inc.: GameSquare's Stream Hatchet Publishes Q3 Report | Live Streaming Insights Show Major Growth in Gaming Content EngagementNew Report Reveals Today's Top CreatorsView the report: https://streamhatchet.com/q3-2024-live-streaming-trend-report/ FRISCO, TX... ► Artikel lesen | |
| 15.11. | GameSquare Holdings, Inc. - 8-K, Current Report |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Outlook Therapeutics, Inc. - 8-K, Current Report | ||
| 13.12. | Outlook Therapeutics, Inc.: Outlook Therapeutics Streamlines Operations | ISELIN, N.J., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the United Kingdom... ► Artikel lesen | |
| 04.12. | Outlook Therapeutics, Inc.: Outlook Therapeutics Announces NICE Recommendation of LYTENAVA (bevacizumab gamma) for the Treatment of Wet AMD | First positive reimbursement decision worldwide for LYTENAVA; First launch anticipated in H1 2025
LYTENAVA is the first and only approved ophthalmic formulation of bevacizumab for the treatment... ► Artikel lesen | |
| 03.12. | Outlook Therapeutics announces CEO resignation | ||
| 03.12. | Outlook Therapeutics ernennt Interims-CEO und plant Produkteinführung |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.03. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 13.03.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 13.03.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 13.03.2024ISIN NameCA3649341094 GAMESQUARE... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| GAMESQUARE HOLDINGS INC | 0,781 | -4,77 % |
| OUTLOOK THERAPEUTICS INC | 1,390 | +0,72 % |
| VAXXA AB | 0,089 | -4,84 % |
